Skip to main content

Table 3 The number and percentage of participants with abnormal measures at baseline and follow-up and the number and percentage with normalized measures at follow-up of those with abnormal baseline measures

From: A real-world evaluation of a tertiary care childhood obesity intervention to reduce metabolic risk in a hard-to-reach urban population

Measure Abnormal at Baseline
N (%)
Normalized measure at follow-up of those with abnormal measure at baseline
N (%)
Abnormal at Follow-up p value*
Waist Circumferencea 133 (92.4%) 10 (7.5%) 127 (88.2%) p = 0.180
Blood Pressureb
 Systolic blood pressure 64 (44.4%) 33 (51.6%) 55 (38.2%) p = 0.289
 Diastolic blood pressure 20 (13.9%) 18 (90.0%) 15 (10.4%) p = 0.473
Lipid Levelsc
 Total cholesterol 67 (46.5%) 16 (23.9%) 65 (45.1%) p = 0.856
 High-density lipoprotein 48 (33.3%) 22 (45.8%) 38 (26.4%) p = 0.121
 Low-density lipoprotein 50 (34.7%) 13 (26.0%) 54 (37.5%) p = 0.585
 Triglycerides 37 (25.7%) 18 (48.6%) 39 (27.1%) p = 0.871
Fasting Glucosed 7 (4.9%) 6 ((85.7%) 3 (2.1%) p = 0.289
Presence of 3 or more components of the metabolic syndromee 44 (30.6%) 22 (50.0%) 39 (27.1%) p = 0.522
  1. *p-values refer to McNemar tests
  2. aWaist circumference ≥ 90th percentile for age and sex was defined as abnormal [14]
  3. bHypertension was defined as SBP or DBP ≥ 90th percentile for age, sex, and height [14]
  4. cAbnormal lipid levels were defined as: TC ≥ 160 mg/dL; HDL ≤ 40 mg/dL; LDL ≥ 110 mg/dL; and TG ≥ 110 mg/dL for those 12 yrs. and older or ≥ 90th percentile for age and sex [14]
  5. dAbnormally high fasting glucose level was defined as ≥110 mg/dL [14]
  6. eDefined as presence of 3 or more of the following: increased waist circumference, systolic or diastolic hypertension, a high TG level, a low HDL level, or elevated fasting glucose concentration